Regrow Biosciences gets USFDA Nod for Phase II trials of ‘OSSGROW’ for Osteonecrosis in the US
OSSGROW is India's first FDA (DCGI) approved product that has treated over 1000 patients across 200 hospitals in the country ...
Tag: Regrow Biosciences
Amit Raman, GM of Radisson Blu Pune Hinjawadi, Recognized in Hozpitality’s Best 30 GM Powerlist in India – 2024
Pune, (Maharashtra), , January 10, 2025: In a testament to his exceptional leadership and commitment to excellence, Mr. Amit Raman,...
Read more
